China Shineway Pharmaceutical Group Limited

CSWYY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$1,146$1,240$723$557
Dep. & Amort.$69$177$186$182
Deferred Tax$0$0$0$207
Stock-Based Comp.$0$0$0$0
Change in WC$222-$94-$228-$207
Other Non-Cash-$473-$391$429-$36
Operating Cash Flow$963$933$1,110$703
Investing Activities
PP&E Inv.-$140-$144-$129-$94
Net Acquisitions$2$0$1$9
Inv. Purchases-$845-$520-$320-$370
Inv. Sales/Matur.$528$531$307$379
Other Inv. Act.$183$84$97$470
Investing Cash Flow-$272-$50-$45$395
Financing Activities
Debt Repay.$30$300$0-$369
Stock Issued$0$0$0$4
Stock Repurch.$0$0$0$0
Dividends Paid-$408-$317-$242-$453
Other Fin. Act.-$15-$9-$8-$10
Financing Cash Flow-$392-$27-$250-$829
Forex Effect-$47$6$6-$7
Net Chg. in Cash$251$863$821$263
Supplemental Information
Beg. Cash$5,889$5,026$4,206$3,943
End Cash$6,140$5,889$5,026$4,206
Free Cash Flow$823$788$980$610